Allan Brett to Minimal Clinically Important Difference
This is a "connection" page, showing publications Allan Brett has written about Minimal Clinically Important Difference.
Connection Strength
0.175
-
A Clinical Overview of Off-label Use of Gabapentinoid Drugs. JAMA Intern Med. 2019 05 01; 179(5):695-701.
Score: 0.175
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.